The Level of Estrogen and Progesterone Receptor Immunoreactivity Correlates With Time to Disease Recurrence in Hormone Receptor-Positive Breast Cancer

被引：0
|
作者：
Winner, Megan [1 ]
Rosman, Martin [2 ]
Mylander, Charles [2 ]
Jackson, Rubie Sue [2 ]
Pozo, Marcos [1 ]
Umbricht, Christopher [3 ]
Tafra, Lorraine [2 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[2] Anne Arundel Med Ctr, Annapolis, MD USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0235
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [1] Patients With Only 1 Positive Hormone Receptor Have Increased Locoregional Recurrence Compared With Patients With Estrogen Receptor-Positive Progesterone Receptor-Positive Disease in Very Early Stage Breast Cancer
    Albert, Jeffrey M.
    Gonzalez-Angulo, Ana M.
    Guray, Merih
    Sahin, Aysegul
    Tereffe, Welela
    Woodward, Wendy A.
    Strom, Eric A.
    Hunt, Kelly K.
    Tucker, Susan L.
    Buchholz, Thomas A.
    CANCER, 2011, 117 (08) : 1595 - 1601
  • [2] Progesterone receptor signaling in estrogen receptor-positive breast cancer.
    Young, Amy
    Guan, Jane
    Daemen, Anneleen
    Friedman, Lori
    Lin, Kui
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 81 - 81
  • [3] Estrogen receptor β- an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?
    Maehle, Bjorn O.
    Collett, Karin
    Tretli, Steinar
    Akslen, Lars A.
    Grotmol, Tom
    APMIS, 2009, 117 (09) : 644 - 650
  • [4] Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence
    Bogina, Giuseppe
    Lunardi, Gianluigi
    Coati, Francesca
    Zamboni, Giuseppe
    Gori, Stefania
    Bortesi, Laura
    Marconi, Marcella
    Cassandrini, Paola Agnese
    Turazza, Monica
    Cortesi, Laura
    DeMatteis, Elisabetta
    Ficarra, Guido
    Ibrahim, Toni
    Serra, Patrizia
    Medri, Laura
    Giraudi, Sara
    Lambertini, Matteo
    Carli, Franca
    Foglietta, Jennifer
    Sidoni, Angelo
    Nunzi, Martina
    Ficorella, Corrado
    Diadema, Maria Rosaria
    Del Mastro, Lucia
    TUMORI JOURNAL, 2015, 101 (04): : 398 - 403
  • [5] Hormone receptor expression level and nuclear grade associated with late recurrence in estrogen receptor-positive breast cancer patients
    Iwase, M.
    Hayashi, N.
    Yoshida, A.
    Kajiura, Y.
    Takahashi, Y.
    Takei, J.
    Suzuki, K.
    Nakamura, S.
    Yamauchi, H.
    CANCER RESEARCH, 2016, 76
  • [6] Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    HUMAN PATHOLOGY, 2015, 46 (11) : 1776 - 1784
  • [7] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Wu, Lunpo
    Wang, Qinghua
    Zhou, Shishi
    Tang, Wanfen
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Hong, Zhongwu
    Fu, Jianfei
    Du, Jinlin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1145 - 1153
  • [8] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Hongjuan Zheng
    Chenyang Ge
    Haiping Lin
    Lunpo Wu
    Qinghua Wang
    Shishi Zhou
    Wanfen Tang
    Xia Zhang
    Xiayun Jin
    Xifeng Xu
    Zhongwu Hong
    Jianfei Fu
    Jinlin Du
    International Journal of Clinical Oncology, 2022, 27 : 1145 - 1153
  • [9] Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer
    Kim, HJ
    Cui, XJ
    Hilsenbeck, SG
    Lee, AV
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 1013S - 1018S
  • [10] Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer
    Nikoic-Vukosavljevic, D
    Kanjer, K
    Neskovic-Konstantinovic, Z
    Vukotic, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 196 - 200
12345